ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$96.85

Market cap

$168.07B

P/E Ratio

32.83

Dividend/share

$2

EPS

$2.95

Enterprise value

$177.08B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
ABT's P/E is 26% below its 5-year quarterly average of 44.3 but 12% above its last 4 quarters average of 29.3
Abbott Laboratories's net income has decreased by 40% YoY and by 11% QoQ
The EPS has contracted by 39% YoY and by 11% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$168.07B
Enterprise value
$177.08B
Valuations
Price to earnings (P/E)
32.83
Price to book (P/B)
4.5
Price to sales (P/S)
4.19
EV/EBIT
25.73
EV/EBITDA
17.51
EV/Sales
4.4
Earnings
Revenue
$40.23B
EBIT
$6.88B
EBITDA
$10.11B
Free cash flow
$5.49B
Per share
EPS
$2.95
Free cash flow per share
$3.15
Book value per share
$21.51
Revenue per share
$23.11
TBVPS
$23.13
Balance sheet
Total assets
$73.35B
Total liabilities
$35.95B
Debt
$16.85B
Equity
$37.4B
Working capital
$9.16B
Liquidity
Debt to equity
0.45
Current ratio
1.64
Quick ratio
1
Net debt/EBITDA
0.89
Margins
EBITDA margin
25.1%
Gross margin
55.2%
Net margin
12.8%
Operating margin
15.2%
Efficiency
Return on assets
7%
Return on equity
14%
Return on invested capital
20.4%
Return on capital employed
11.7%
Return on sales
17.1%
Dividend
Dividend yield
2.07%
DPS
$2
Payout ratio
67.8%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-1.29%
1 week
-1.32%
1 month
-6.76%
1 year
-1.47%
YTD
-11.79%
QTD
-11.16%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.23B
Gross profit
$22.19B
Operating income
$6.13B
Net income
$5.16B
Gross margin
55.2%
Net margin
12.8%
Abbott Laboratories's net income has decreased by 40% YoY and by 11% QoQ
The operating income has contracted by 40% YoY and by 12% from the previous quarter
Abbott Laboratories's net margin has decreased by 32% YoY and by 9% QoQ
Abbott Laboratories's operating margin has decreased by 32% YoY and by 10% from the previous quarter

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
ABT P/E details
P/E
32.83
P/B
4.5
P/S
4.19
EV/EBIT
25.73
EV/EBITDA
17.51
EV/Sales
4.4
The EPS has contracted by 39% YoY and by 11% from the previous quarter
ABT's P/E is 26% below its 5-year quarterly average of 44.3 but 12% above its last 4 quarters average of 29.3
ABT's price to book (P/B) is 13% lower than its 5-year quarterly average of 5.2 and 8% lower than its last 4 quarters average of 4.9
ABT's P/S is 13% below its 5-year quarterly average of 4.8 and 2.6% below its last 4 quarters average of 4.3
The revenue has contracted by 12% YoY and by 3.1% from the previous quarter

Efficiency

How efficient is Abbott Laboratories business performance
ABT's ROE is down by 41% YoY and by 11% from the previous quarter
Abbott Laboratories's return on assets has decreased by 39% YoY and by 11% QoQ
The ROIC has contracted by 34% YoY and by 9% from the previous quarter
The ROS has contracted by 26% YoY and by 6% from the previous quarter

Dividends

What is ABT's dividend history
Dividend details
DPS
$2
Dividend yield
2.07%
Payout ratio
67.8%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 104% more than the total liabilities
ABT's quick ratio is down by 25% year-on-year and by 7% since the previous quarter
The current ratio has decreased by 18% YoY and by 2.4% QoQ
Abbott Laboratories's debt is 55% lower than its equity
Abbott Laboratories's debt to equity has decreased by 2.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.